Rochelle Fuhrmann

Rochelle Fuhrmann

Director of Finance/CFO at
Maternal Newborn Health Innovations Corp.
56 year
Health Technology
Finance
Consumer Services

Profile

Rochelle Fuhrmann is currently Chief Financial Officer-Life Sciences at Dickinson & Co. and Chief Financial Officer at Maternal Newborn Health Innovations PBC.
Former roles include Independent Director at Histogen, Inc., Director-Accounting Policy at AT&T, Inc. from 1996 to 2006, Independent Non-Executive Director at Advanz Pharma Corp.
Ltd. from 2015 to 2018, Director at Advanz Pharma Corp.
(Ontario), Vice President-Audit & Enterprise Risk Management at Becton, Dickinson & Co. from 2017 to 2022, Chief Financial Officer at Amneal Pharmaceuticals LLC from 2014 to 2015, Senior VP-Finance & Head-Investor Relations at Warner Chilcott Plc in 2013, and Chief Financial Officer & Senior Vice President at Becton Dickinson India Pvt Ltd. Education includes undergraduate studies at the University of Rhode Island.

Rochelle Fuhrmann active positions

CompaniesPositionStart
Corporate Officer/Principal -
Director of Finance/CFO -

Former positions of Rochelle Fuhrmann

CompaniesPositionEnd
BECTON, DICKINSON AND COMPANY Comptroller/Controller/Auditor 2022-09-30
ADVANZ PHARMA CORP. LIMITED Director/Board Member 2018-09-05
Director of Finance/CFO 2015-02-28
Investor Relations Contact 2013-10-31
AT&T INC. Corporate Officer/Principal 2005-12-31
See the detail of Rochelle Fuhrmann's experience

Training of Rochelle Fuhrmann

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Finance

Consumer Services

Communications

Health Technology

Technology Services

Health Technology

Health Technology

Health Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Rochelle Fuhrmann